2 completed, 1 unknown, 1 withdrawn. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Unknown 1, Withdrawn 1 |
Follow Pulmonary Artery Hypertension: new trials by email Literature Review of Pulmonary Artery Hypertension trials Research Report on Pulmonary Artery Hypertension
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Xenon MRI in Stable Pulmonary Hypertension (Jupiter AUGEAN) Hyperpolarized Xe129 - Pulmonary Artery Hypertension | Phase 2 | Withdrawn | Bastiaan Driehuys | 2024-03-15 | 2024-01-23 | |
| GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) GB002 (seralutinib), Placebo, Generic Dry Powder Inhaler - Pulmonary Artery Hypertension | Phase 2 | Completed | GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. | 86 | 2020-11-12 | 2023-11-07 |
| Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension Metformin, Placebo, mHealth Intervention - Pulmonary Artery Hypertension | Phase 2 | Completed | Vanderbilt University Medical Center | 73 | 2018-08-23 | 2026-09-16 |
| Trimetazidine in Pulmonary Artery Hypertension Trimetazidine - Pulmonary Artery Hypertension | Phase 2 | Unknown | Pontificia Universidad Catolica de Chile | 25 | 2014-03-01 | 2014-04-03 |
Familial Primary Pulmonary Hypertension (4)
Hypertension, Pulmonary (4) · Lung Diseases (4) · Respiratory Tract Diseases (4)
Metformin (1) · Trimetazidine (1)
Bastiaan Driehuys (1) · GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. (1) · Pontificia Universidad Catolica de Chile (1) · Vanderbilt University Medical Center (1)
United States (2) · Australia (1) · Austria (1) · Belgium (1) · Canada (1) · Chile (1) · Czechia (1) · France (1) · Germany (1) · Serbia (1) · Spain (1) · United Kingdom (1)
Anna R Hemnes, MD (1) · Pablo F Castro, MD (1) · Richard Aranda (1) · Sudarshan Rajagopal, MD (1)